Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RSscan is a leading medical technology company specializing in high-end pressure measurement systems and digital gait analysis. The company is internationally recognized for its proprietary footscan® technology, which provides high-speed, high-resolution biomechanical data for clinical, research, and elite sports applications. In 2020, RSscan was acquired by Materialise, a pioneer in 3D printing, to integrate gait analysis data into an end-to-end digital workflow for personalized orthopedics. Their primary commercial offering, Phits 3D-printed insoles, utilizes RSscan data to create custom-engineered orthotics tailored to individual movement patterns. The company's products are widely used by podiatrists, orthopedic surgeons, and professional athletic organizations to improve patient mobility and performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RSscan.